September 30, 2014
Boston, MA
There have been a plethora of decisions addressing complex patent issues in the pharmaceutical and biotech space at all levels of the judicial system, forcing companies and the USPTO to rapidly adjust. This program will address recent case law and delve into how those decisions are impacting the parties’ efforts to settle ANDA litigations and properly draft claims to encompass patentable subject matter. Topics to be discussed include:
Speakers:
Howard W. Levine
Alissa K. Lipton
Leslie A. McDonell
Sanya Sukduang
Date:
Tuesday, September 30, 2014
Time:
9:15 - 9:45 a.m. – Registration and Breakfast
9:45 a.m. - 12:00 p.m. – Workshop
12:00 - 12:30 p.m. – Working Lunch
12:30 - 3:00 p.m. – Workshop
Location:
Finnegan
Two Seaport Lane
Boston, MA 02210
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Conference
Boston Intellectual Property Law Association 4th Annual Symposium
April 10-11, 2024
Boston
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.